The promising AChE and BChE inhibitory capabilities of our synthesised chromium oxide nanoparticles implies that such NPs could be used therapeutically in neurodegenerative illnesses, including Alzheimer’s disease. This evidence concerns the gene BCHE and Alzheimer disease.